Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone for Fatigue in Prostate Cancer Patients on ADT
NCT07224009Phase 2Recruiting
- Sponsor
- University of Arkansas
- Start
- Aug 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in cancer-related fatigue (CRF), sponsored by University of Arkansas. Started Aug 2026; status: recruiting.
02
Drugs
naltrexone
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT07224009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224009.